Point-of-care biomarker assay for traumatic brain injury

(Mary Ann Liebert, Inc./Genetic Engineering News) Intracranial abnormalities on CT scan in patients with traumatic brain injury (TBI) can be predicted by glial fibrillary acidic protein (GFAP) levels in the blood.